BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19385151)

  • 1. Canadian Association of Radiologists national advisory on gadolinium administration and nephrogenic systemic fibrosis.
    Padilla-Thornton A; Zand KR; Barrett B; Stein L; Andrew G; Forster BB
    Can Assoc Radiol J; 2008 Dec; 59(5):237-40. PubMed ID: 19385151
    [No Abstract]   [Full Text] [Related]  

  • 2. Gadolinium and nephrogenic systemic fibrosis.
    Runge VM
    AJR Am J Roentgenol; 2009 Apr; 192(4):W195-6; discussion W197. PubMed ID: 19304681
    [No Abstract]   [Full Text] [Related]  

  • 3. The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents.
    Costa AF
    Can Assoc Radiol J; 2020 Nov; 71(4):536. PubMed ID: 32063014
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 1.
    Thomsen HS
    Acta Radiol; 2016 May; 57(5):515-20. PubMed ID: 26802069
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium and systemic fibrosis: guilt by association.
    Kay J; Czirják L
    Ann Rheum Dis; 2010 Nov; 69(11):1895-7. PubMed ID: 20959325
    [No Abstract]   [Full Text] [Related]  

  • 6. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL
    J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract]   [Full Text] [Related]  

  • 7. Special issue: nephrogenic systemic fibrosis.
    Leiner T; Kucharczyk W
    J Magn Reson Imaging; 2009 Dec; 30(6):1233-5. PubMed ID: 19938034
    [No Abstract]   [Full Text] [Related]  

  • 8. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL; Edward M
    AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.
    Dawson P
    J Magn Reson Imaging; 2008 Oct; 28(4):797-804. PubMed ID: 18821621
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction to the relative risk calculation for gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis.
    Jain R; Levine M
    Radiology; 2010 Apr; 255(1):307-8; author reply 308. PubMed ID: 20308469
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis: the need for accurate case reporting.
    Spinazzi A; Kirchin MA; Pirovano G
    J Magn Reson Imaging; 2009 May; 29(5):1240; author reply 1241. PubMed ID: 19388104
    [No Abstract]   [Full Text] [Related]  

  • 13. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
    Stratta P; Canavese C; Quaglia M; Fenoglio R
    Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
    Thomsen HS; Morcos SK; Almén T; Bellin MF; Bertolotto M; Bongartz G; Clement O; Leander P; Heinz-Peer G; Reimer P; Stacul F; van der Molen A; Webb JA;
    Eur Radiol; 2013 Feb; 23(2):307-18. PubMed ID: 22865271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 2.
    Thomsen HS
    Acta Radiol; 2016 Jun; 57(6):643-8. PubMed ID: 26802070
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
    Yee J
    Adv Chronic Kidney Dis; 2017 May; 24(3):133-135. PubMed ID: 28501073
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
    Wang SC
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):305-6. PubMed ID: 18811752
    [No Abstract]   [Full Text] [Related]  

  • 19. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
    Tamburrini O; Balducci A
    Radiol Med; 2012 Feb; 117(1):1-5. PubMed ID: 22020430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
    Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
    J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.